Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients

Lucia Del Mastro, Matteo Lambertini, Claudia Bighin, Alessia Levaggi, Alessia D'Alonzo, Sara Giraudi, Paolo Pronzato

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences